Neuvotion Announces Commercialization of Brain-Computer Interface and Brain-Body Interface Technologies – Related Clinical Study Published in Nature Medicine

Summary

Neuvotion announced commercialization of its AI-guided neuromodulation and brain-computer interface technologies, including the FDA-cleared NeuStim wearable muscle stimulation system for post-stroke and spinal cord injury recovery. A concurrent Nature Medicine study demonstrated a double neural bypass restoring both movement and sensation in a participant with complete paralysis, with lasting gains in strength and touch. The platform integrates wearable stimulation, spinal neuromodulation, and minimally invasive BCI to promote neuroplasticity and functional recovery.